These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 15837753
21. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, Steineck G, Adolfsson J, Larsson P, Norming U, Wijkström H, Hemminki K. Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475 [Abstract] [Full Text] [Related]
22. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred. Petronzelli F, Sollima D, Coppola G, Martini-Neri ME, Neri G, Genuardi M. Genes Chromosomes Cancer; 2001 Aug; 31(4):398-401. PubMed ID: 11433531 [Abstract] [Full Text] [Related]
23. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia. Kresty LA, Mallery SR, Knobloch TJ, Li J, Lloyd M, Casto BC, Weghorst CM. Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760 [Abstract] [Full Text] [Related]
24. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia. Faderl S, Estrov Z, Kantarjian HM, Thomas D, Cortes J, Manshouri T, Chan CC, Hays KJ, Pierce S, Albitar M. Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574 [Abstract] [Full Text] [Related]
25. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma. Inda MM, Muñoz J, Coullin P, Fauvet D, Danglot G, Tuñón T, Bernheim A, Castresana JS. Histopathology; 2006 Apr; 48(5):579-87. PubMed ID: 16623784 [Abstract] [Full Text] [Related]
26. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Labuhn M, Jones G, Speel EJ, Maier D, Zweifel C, Gratzl O, Van Meir EG, Hegi ME, Merlo A. Oncogene; 2001 Mar 01; 20(9):1103-9. PubMed ID: 11314047 [Abstract] [Full Text] [Related]
27. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma. Obermann EC, Diss TC, Hamoudi RA, Munson P, Wilkins BS, Camozzi ML, Isaacson PG, Du MQ, Dogan A. J Pathol; 2004 Feb 01; 202(2):252-62. PubMed ID: 14743509 [Abstract] [Full Text] [Related]
28. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M. Biochem Biophys Res Commun; 2006 Jan 20; 339(3):790-6. PubMed ID: 16316628 [Abstract] [Full Text] [Related]
29. Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes. Bloethner S, Hemminki K, Thirumaran RK, Chen B, Mueller-Berghaus J, Ugurel S, Schadendorf D, Kumar R. Melanoma Res; 2006 Aug 20; 16(4):297-307. PubMed ID: 16845325 [Abstract] [Full Text] [Related]
30. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells. Zhang H, Rosdahl I. Int J Oncol; 2004 Feb 20; 24(2):331-5. PubMed ID: 14719109 [Abstract] [Full Text] [Related]
31. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group. Palmieri G, Cossu A, Ascierto PA, Botti G, Strazzullo M, Lissia A, Colombino M, Casula M, Floris C, Tanda F, Pirastu M, Castello G, Melanoma Cooperative Group. Br J Cancer; 2000 Dec 20; 83(12):1707-14. PubMed ID: 11104570 [Abstract] [Full Text] [Related]
32. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS. Ophthalmology; 2007 Apr 20; 114(4):774-9. PubMed ID: 17207529 [Abstract] [Full Text] [Related]
33. Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis. Pineau P, Marchio A, Nagamori S, Seki S, Tiollais P, Dejean A. Hepatology; 2003 Apr 20; 37(4):852-61. PubMed ID: 12668978 [Abstract] [Full Text] [Related]
34. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma. García-Castellano JM, Villanueva A, Healey JH, Sowers R, Cordon-Cardo C, Huvos A, Bertino JR, Meyers P, Gorlick R. Clin Cancer Res; 2002 Mar 20; 8(3):782-7. PubMed ID: 11895909 [Abstract] [Full Text] [Related]
35. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas. Kirsch M, Mörz M, Pinzer T, Schackert HK, Schackert G. Genes Chromosomes Cancer; 2009 Feb 20; 48(2):143-54. PubMed ID: 18973139 [Abstract] [Full Text] [Related]
36. Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Calero Moreno TM, Gustafsson G, Garwicz S, Grandér D, Jonmundsson GK, Frost BM, Mäkipernaa A, Rasool O, Savolainen ER, Schmiegelow K, Söderhäll S, Vettenranta K, Wesenberg F, Einhorn S, Heyman M. Leukemia; 2002 Oct 20; 16(10):2037-45. PubMed ID: 12357355 [Abstract] [Full Text] [Related]
37. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma. Ariyanayagam-Baksh SM, Baksh FK, Swalsky PA, Finkelstein SD. Mod Pathol; 2003 Oct 20; 16(10):992-5. PubMed ID: 14559981 [Abstract] [Full Text] [Related]
38. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma. Fujimoto A, Morita R, Hatta N, Takehara K, Takata M. Oncogene; 1999 Apr 15; 18(15):2527-32. PubMed ID: 10229204 [Abstract] [Full Text] [Related]
39. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Scholes AG, Liloglou T, Maloney P, Hagan S, Nunn J, Hiscott P, Damato BE, Grierson I, Field JK. Invest Ophthalmol Vis Sci; 2001 Oct 15; 42(11):2472-7. PubMed ID: 11581185 [Abstract] [Full Text] [Related]
40. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Kwong RA, Kalish LH, Nguyen TV, Kench JG, Bova RJ, Cole IE, Musgrove EA, Sutherland RL. Clin Cancer Res; 2005 Jun 01; 11(11):4107-16. PubMed ID: 15930346 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]